Esperion Therapeutics, Inc. (ESPR)
2.14
-0.08
(-3.60%)
USD |
NASDAQ |
Apr 14, 12:01
Esperion Therapeutics Cash from Investing (TTM) : 0.00 for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Nektar Therapeutics | -1.197M |
| Harrow, Inc. | -5.46M |
| Corcept Therapeutics, Inc. | 69.76M |
| Catalyst Pharmaceuticals, Inc. | -0.058M |
| Regeneron Pharmaceuticals, Inc. | -629.10M |